Rationale for IL-36 receptor antibodies in ulcerative colitis

EXPERT OPINION ON BIOLOGICAL THERAPY

TAYLOR & FRANCIS LTD

1. DFG [SFB 1181-C02, TRR241-A08, TRR241-C02, FOR 2438, NE1927/2-2]
2. German Research Council DFG